Literature DB >> 11892061

Overview of ocular allergy treatment.

M Friedlaender1.   

Abstract

A plethora of drugs is available for the treatment of ocular allergy. Traditional treatment includes antihistamine and antihistamine/vasoconstrictor combination eyedrops. These drugs are useful, safe, and readily available. Mast cell stabilizers are safe, effective, and an important component of antiallergic therapy. Nonsteroidal anti-inflammatory drugs also have antiallergic effects. In recent years, drugs with multiple mechanisms of action have proven to be effective antiallergics. These drugs often have mast cell stabilizing, antihistaminic, and anti-inflammatory properties. Corticosteroids are considered to be more potent than other antiallergic drugs, and modifications in their molecular structures have made certain corticosteroids suitable for the treatment of ocular allergy.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11892061     DOI: 10.1007/s11882-001-0051-1

Source DB:  PubMed          Journal:  Curr Allergy Asthma Rep        ISSN: 1529-7322            Impact factor:   4.806


  22 in total

1.  Conjunctival provocative tests: a model of human ocular allergy.

Authors:  M H Friedlaender
Journal:  Trans Am Ophthalmol Soc       Date:  1989

2.  Efficacy of lodoxamide eye drops on mast cells and eosinophils after allergen challenge in allergic conjunctivitis.

Authors:  S Bonini; M Schiavone; S Bonini; L Magrini; P Lischetti; A Lambiase; M G Bucci
Journal:  Ophthalmology       Date:  1997-05       Impact factor: 12.079

Review 3.  Allergic and immunologic disorders of the eye. Part I: immunology of the eye.

Authors:  L Bielory
Journal:  J Allergy Clin Immunol       Date:  2000-11       Impact factor: 10.793

4.  A controlled evaluation of the efficacy and safety of loteprednol etabonate in the prophylactic treatment of seasonal allergic conjunctivitis. Loteprednol Allergic Conjunctivitis Study Group.

Authors:  S J Dell; D G Shulman; G M Lowry; J Howes
Journal:  Am J Ophthalmol       Date:  1997-06       Impact factor: 5.258

Review 5.  Treating severe eye allergy.

Authors:  P Verin
Journal:  Clin Exp Allergy       Date:  1998-12       Impact factor: 5.018

6.  A randomized, double-masked, placebo-controlled parallel study of 0.2% loteprednol etabonate in patients with seasonal allergic conjunctivitis.

Authors:  S J Dell; G M Lowry; J A Northcutt; J Howes; G D Novack; K Hart
Journal:  J Allergy Clin Immunol       Date:  1998-08       Impact factor: 10.793

7.  Allergic eye disease--a clinical challenge.

Authors:  R J Buckley
Journal:  Clin Exp Allergy       Date:  1998-12       Impact factor: 5.018

8.  Nedocromil sodium eye drops are more effective than sodium cromoglycate eye drops for the long-term management of vernal keratoconjunctivitis.

Authors:  P H Verin; I D Dicker; B Mortemousque
Journal:  Clin Exp Allergy       Date:  1999-04       Impact factor: 5.018

9.  Azelastine eye drops in the treatment of seasonal allergic conjunctivitis or rhinoconjunctivitis in young children.

Authors:  A Sabbah; M Marzetto
Journal:  Curr Med Res Opin       Date:  1998       Impact factor: 2.580

10.  A randomized, placebo-controlled trial of topical cyclosporin A in steroid-dependent atopic keratoconjunctivitis.

Authors:  M Hingorani; L Moodaley; V L Calder; R J Buckley; S Lightman
Journal:  Ophthalmology       Date:  1998-09       Impact factor: 12.079

View more
  5 in total

1.  Bromfenac ophthalmic solution 0.09 %: human aqueous humor concentration detected by high-performance liquid chromatography.

Authors:  Angelo Macrì; Aldo Vagge; Annalisa Salis; Carmen Fucile; Valeria Marini; Antonietta Martelli; Sebastiano Giuffrida; Michele Iester; Gianluca Damonte; Francesca Mattioli
Journal:  Int Ophthalmol       Date:  2016-06-20       Impact factor: 2.031

2.  Allergic conjunctivitis at sheikh zayed regional eye care center, gambia.

Authors:  Patricia D Wade; Anthonia N Iwuora; Laritza Lopez; Mustapha A Muhammad
Journal:  J Ophthalmic Vis Res       Date:  2012-01

3.  Corneal sensitivity after topical bromfenac sodium eye-drop instillation.

Authors:  Kaori Yanai; Jane Huang; Kazuaki Kadonosono; Eiichi Uchio
Journal:  Clin Ophthalmol       Date:  2013-04-17

4.  Allergic conjunctivitis in Jos-Nigeria.

Authors:  Keziah N Malu
Journal:  Niger Med J       Date:  2014-03

5.  Histamine Regulates Molecular Clock Oscillations in Human Retinal Pigment Epithelial Cells via H1 Receptors.

Authors:  Eri Morioka; Yuzuki Kanda; Hayato Koizumi; Tsubasa Miyamoto; Masayuki Ikeda
Journal:  Front Endocrinol (Lausanne)       Date:  2018-03-19       Impact factor: 5.555

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.